ArticleAnnals of translational medicine2021

Two severe adverse events triggered by an anti-PD-1 immune checkpoint inhibitor in an advanced lung cancer patient: a case report and review of the literature.

Zhiyao Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.